| EVIFX | RLBEX | EVIFX / RLBEX | |
| Total Expense Ratio | 0.96 | 0.60 | 160% |
| Annual Report Gross Expense Ratio | 0.96 | 0.60 | 160% |
| Fund Existence | 94 years | 24 years | - |
| Gain YTD | 3.618 | 8.389 | 43% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.04B | 288B | 0% |
| Annual Yield % from dividends | 1.13 | 1.79 | 63% |
| Returns for 1 year | 3.54 | 11.29 | 31% |
| Returns for 3 years | 32.74 | 38.57 | 85% |
| Returns for 5 years | 13.47 | 32.29 | 42% |
| Returns for 10 years | 66.72 | 84.73 | 79% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSFBX | 26.96 | 0.19 | +0.71% |
| Morgan Stanley Inst Global Franchise A | |||
| ISVGX | 22.69 | 0.13 | +0.58% |
| Voya Growth and Income Port S | |||
| BRUGX | 18.69 | 0.06 | +0.32% |
| MFS Blended Research Value Equity C | |||
| HHCCX | 14.27 | -0.04 | -0.28% |
| NexPoint Event Driven C | |||
| TRMIX | 38.56 | -0.13 | -0.34% |
| T. Rowe Price Mid-Cap Value I | |||